Filippo Sladojevich, Ph.D.

Senior Principal Scientist at Hoffmann-La Roche

Speaker

Filippo Sladojevich is currently a Senior Principal Scientist at Hoffmann-La Roche in Basel (Switzerland), where he is responsible for several technical activities related to the early development of the Oligonucleotides and Peptides portfolio. Filippo’s scientific interests encompass the research and development of new therapeutics in the new and mixed-modality spaces and the identification of innovative solutions to enable sustainable manufacturing technologies in the TIDES space.

Filippo Sladojevich earned his PhD from the University of Florence (Italy) and had postdoctoral training at Oxford University, Harvard, and ETH, working on total synthesis, catalysis, and radiochemistry. Prior to joining Roche, Filippo worked at Philochem AG, a biotechnology company specialized in DNA-encoded library technologies and radiotherapeutics. Dr. Sladojevich is the coauthor of over 40 publications and patents.